Published in J Neurovirol on February 28, 2017
A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol (2003) 102.57
MUSCLE: a multiple sequence alignment method with reduced time and space complexity. BMC Bioinformatics (2004) 50.89
HyPhy: hypothesis testing using phylogenies. Bioinformatics (2004) 17.33
Estimation of levels of gene flow from DNA sequence data. Genetics (1992) 9.82
The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS (2005) 4.48
Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci (2001) 3.11
Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy. Clin Infect Dis (2010) 2.90
Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options. AIDS Res Ther (2007) 2.65
Viral sanctuaries during highly active antiretroviral therapy in a nonhuman primate model for AIDS. J Virol (2009) 2.37
Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry (1994) 1.98
Immune activation of the central nervous system is still present after >4 years of effective highly active antiretroviral therapy. J Infect Dis (2007) 1.92
Profile of neurologic disorders associated with HIV/AIDS from Bangalore, south India (1989-96). Indian J Med Res (2000) 1.87
Tat protein of human immunodeficiency virus type 1 subtype C strains is a defective chemokine. J Virol (2004) 1.85
Comparative study of methods for detecting sequence compartmentalization in human immunodeficiency virus type 1. J Virol (2007) 1.71
Compartmentalization and clonal amplification of HIV-1 variants in the cerebrospinal fluid during primary infection. J Virol (2009) 1.70
Increased human immunodeficiency virus type 1 (HIV-1) env compartmentalization in the presence of HIV-1-associated dementia. J Virol (2005) 1.65
Early penetration of the blood-brain-barrier by HIV. Neurology (1988) 1.62
CD8 encephalitis in HIV-infected patients receiving cART: a treatable entity. Clin Infect Dis (2013) 1.60
Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid. J Neuroimmunol (1989) 1.59
Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients. Neurology (2006) 1.45
Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease course. AIDS (2009) 1.40
On cerebrospinal fluid immunoglobulin-G (IgG) quotients in multiple sclerosis and other diseases. A review and a new formula to estimate the amount of IgG synthesized per day by the central nervous system. J Neurol Sci (1970) 1.35
Immune reconstitution inflammatory syndrome in HIV. Curr Opin Infect Dis (2006) 1.35
External quality assessment in clinical neurochemistry: survey of analysis for cerebrospinal fluid (CSF) proteins based on CSF/serum quotients. Clin Chem (1995) 1.32
Intrathecal synthesis of antibodies to HTLV-III in patients without AIDS or AIDS related complex. Br Med J (Clin Res Ed) (1986) 1.30
Neurological complications of immune reconstitution in HIV-infected populations. Ann N Y Acad Sci (2010) 1.28
Compartmentalized human immunodeficiency virus type 1 present in cerebrospinal fluid is produced by short-lived cells. J Virol (2005) 1.22
Predominance of distinct viral genotypes in brain and lymph node compartments of HIV-1-infected individuals. Viral Immunol (1991) 1.17
Cerebral CD8+ lymphocytosis in HIV-1 infected patients with immune restoration induced by HAART. Acta Neuropathol (2004) 1.14
Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations. Brain (2002) 1.13
Incidence and prevalence of intrasubtype HIV-1 dual infection in at-risk men in the United States. J Infect Dis (2013) 1.13
Neurocognitive impairment in HIV-1 clade C- versus B-infected individuals in Southern Brazil. J Neurovirol (2013) 1.05
Therapy Insight: CNS manifestations of HIV-associated immune reconstitution inflammatory syndrome. Nat Clin Pract Neurol (2006) 1.04
Therapy failure following selection of enfuvirtide-resistant HIV-1 in cerebrospinal fluid. Clin Infect Dis (2010) 1.02
Cerebrospinal fluid abnormalities in homosexual men with and without neuropsychiatric findings. Ann Neurol (1988) 0.94
HIV encephalitis despite suppressed viraemia: a case of compartmentalized viral escape. Int J STD AIDS (2011) 0.94
Fatal immune reconstitution inflammatory syndrome with human immunodeficiency virus infection and Candida meningitis: case report and review of the literature. J Neurovirol (2008) 0.93
HIV-1 neutralizing antibody response and viral genetic diversity characterized with next generation sequencing. Virology (2014) 0.91
Next generation sequencing improves detection of drug resistance mutations in infants after PMTCT failure. J Clin Virol (2014) 0.87
Neurological complications in AIDS patients receiving HAART: a 2-year retrospective study. Eur J Neurol (2006) 0.87
Increasing intrathecal lymphocytosis and immunoglobulin G production in neurologically asymptomatic HIV-1 infection. J Neuroimmunol (1988) 0.87
Reversible dementia in a patient with central nervous system escape of human immunodeficiency virus. J Infect (2011) 0.86
CSF protein and cellular profiles in various stages of HIV infection related to neurological manifestations. J Neurol Sci (1987) 0.86
CSF changes in a longitudinal study of 124 neurologically normal HIV-1-infected U.S. Air Force personnel. J Acquir Immune Defic Syndr (1991) 0.83
HIV type 1 viral encephalitis after development of viral resistance to plasma suppressive antiretroviral therapy. AIDS Res Hum Retroviruses (2011) 0.83
Myelin basic protein in CSF and blood. Relationship between its presence and the occurrence of a destructive process in the brains of encephalitic patients. Arch Neurol (1982) 0.83
Tissue-specific HIV-1 infection: why it matters. Future Virol (2011) 0.81
Effects of antiretroviral treatment on blood-brain barrier integrity and intrathecal immunoglobulin production in neuroasymptomatic HIV-1-infected patients. HIV Med (2005) 0.81
Cerebrospinal fluid myelin basic protein as predictive marker of demyelination in AIDS dementia complex. J Neuroimmunol (1992) 0.81
Cerebrospinal fluid myelin basic protein is frequently ordered but has little value: a test utilization study. Am J Clin Pathol (2012) 0.81
Immunoglobulins and complement components in 37 patients infected by HIV-1 virus: comparison of general (systemic) and intrathecal immunity. J Neurol Sci (1989) 0.80
Investigation of reference values of components of cerebrospinal fluid. J Clin Chem Clin Biochem (1978) 0.78
Quantitative CSF IgG measurements in multiple sclerosis and other neurologic diseases. An update. Arch Neurol (1983) 0.78
Biomarkers of chemotaxis and inflammation in cerebrospinal fluid and serum in individuals with HIV-1 subtype C versus B. J Neurovirol (2016) 0.78
[CSF levels and diagnostic utility of cerebrospinal fluid beta2-microglobulin]. Ann Biol Clin (Paris) (2005) 0.78
Blood-CSF barrier and compartmentalization of CNS cellular immune response in HIV infection. J Neuroimmunol (2016) 0.76
Intrathecal synthesis of anti-HIV oligoclonal IgG in HIV-seropositive patients having no signs of HIV-induced neurologic diseases. Ann N Y Acad Sci (1988) 0.76
Myelin basic protein in the cerebrospinal fluid of patients infected with HIV. J Neurol (1989) 0.76
Association between intrathecal anti-HIV-1 immunoglobulin G synthesis and occurrence of HIV-1 in cerebrospinal fluid. AIDS (1989) 0.76
Intrathecal IgG synthesis and specificity of oligoclonal IgG in patients infected with HIV-1 do not correlate with CNS disease. J Med Virol (1991) 0.76
Variance estimation for nucleotide substitution models. Mol Phylogenet Evol (2015) 0.76
Apolipoprotein E ε4 genotype status is not associated with neuroimaging outcomes in a large cohort of HIV+ individuals. J Neurovirol (2016) 0.80
Biomarkers of chemotaxis and inflammation in cerebrospinal fluid and serum in individuals with HIV-1 subtype C versus B. J Neurovirol (2016) 0.78
Blood-CSF barrier and compartmentalization of CNS cellular immune response in HIV infection. J Neuroimmunol (2016) 0.76
Suicide risk and prevalence of major depressive disorder (MDD) among individuals infected with HIV-1 subtype C versus B in Southern Brazil. J Neurovirol (2016) 0.75